-
Health todayCancer refines
Smaller colorectal tumours linked to nodal metastasis risk and worse survival in subgroups
In 10,513 colorectal cancer patients, smaller tumour diameter raised predicted lymph node metastasis risk and, below 3 cm, mortality.
Peer-reviewed -
Data, models and systemsWhat linked data reveals refines
Primary care death records match ONS registrations for 88% of deaths in OpenSAFELY-TPP
Of 1,409,275 ONS-registered deaths from 2020 to 2025, 88% had the same date of death in primary care and 8% had none.
Preprint · not peer-reviewed -
Tomorrow's worldA changing climate contradicts
Wildfire smoke PM2.5 in US counties: excess deaths peak three years after exposure
Monthly county-level wildfire PM2.5 and mortality data gave 1.7 million smoke-associated deaths over 2011-2023, about ten times conventional estimates.
Preprint · not peer-reviewed -
Data, models and systemsRevisions and new sources refines
Health opportunity cost estimates updated for 92 low- and middle-income countries
The marginal cost per DALY averted ranges from about $54 to $18,547 across 92 low- and middle-income countries.
Preprint · not peer-reviewed -
Tomorrow's worldChanging behaviour at scale refines
Since 2021, low vaccine coverage predicts larger measles outbreaks in US counties
Since 2021, US counties with lower vaccine coverage have had larger measles outbreaks, and spread to neighbouring counties has increased.
Preprint · not peer-reviewed -
Health todayObesity, diabetes and GLP-1 refines
Type 2 diabetes being diagnosed at older ages in Israel, and with more co-morbidities
Median age at diagnosis rose from 63.0 to 66.7 years between 2005-2008 and 2020-2023 in one Israeli health system.
Peer-reviewed -
Tomorrow's worldSlowing ageing itself refines
Short telomeres, not epigenetic or proteomic ageing, raise interstitial lung disease risk
Of six ageing measures tested against six immune-mediated diseases, only longer leukocyte telomeres lowered interstitial lung disease risk.
Preprint · not peer-reviewed -
Tomorrow's worldInnovation in treatment new
VES001, an oral sortilin inhibitor, raised plasma and CSF progranulin in healthy adults
In a randomised placebo-controlled first-in-human trial, twice-daily oral VES001 for 7 days raised plasma progranulin by up to 49% and CSF progranulin by 18% from baseline.
Peer-reviewed -
Health todayCancer confirms
Cervical cancer screening rises but gaps persist in US medical records, 2019-2024
Screening rates rose in all racial and ethnic groups from 2019 to 2024, with the largest gain among Hispanic patients.
Peer-reviewed -
Data, models and systemsAI in medicine confirms
Machine learning beat risk scores for predicting AF recurrence after catheter ablation
Across 11 studies, machine learning pooled a C-statistic of 0.80 for AF recurrence after ablation, against 0.58 for traditional scores.
Peer-reviewed -
Health todayMental health contradicts
Life expectancy gap for hospitalised psychiatric illness narrowed in Queensland, 2009-2023
The life expectancy gap at age 18 narrowed in both sexes over 14 years, but not in schizophrenia.
Peer-reviewed -
Health todayObesity, diabetes and GLP-1 new
Tirzepatide price rise shifted UK self-paying patients to semaglutide
Among 1,033,522 UK adults self-funding GLP-1 treatment, semaglutide initiation rose 31 percentage points in the month tirzepatide's list price rose.
Peer-reviewed